New Carboxamides and a New Polyketide from the Sponge-Derived Fungus <i>Arthrinium</i> sp. SCSIO 41421

New carboxamides, (±)-vochysiamide C (<b>1</b>) and (+)-vochysiamide B (<b>2</b>), and a new polyketide, 4<i>S</i>,3a<i>S</i>,9a<i>R</i>-3a,9a-deoxy-3a hydroxy-1-dehydroxyarthrinone (<b>3</b>), were isolated and identified from...

Full description

Bibliographic Details
Main Authors: Jianglian She, Yi Chen, Yuxiu Ye, Xiuping Lin, Bin Yang, Jiao Xiao, Yonghong Liu, Xuefeng Zhou
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Marine Drugs
Subjects:
Online Access:https://www.mdpi.com/1660-3397/20/8/475
Description
Summary:New carboxamides, (±)-vochysiamide C (<b>1</b>) and (+)-vochysiamide B (<b>2</b>), and a new polyketide, 4<i>S</i>,3a<i>S</i>,9a<i>R</i>-3a,9a-deoxy-3a hydroxy-1-dehydroxyarthrinone (<b>3</b>), were isolated and identified from the sponge-derived fungus <i>Arthrinium</i> sp. SCSIO 41421, together with other fifteen known natural products (<b>4</b>–<b>18</b>). Their structures including absolute configurations were determined by detailed NMR, MS spectroscopic analyses, calculated electronic circular dichroism (ECD), as well as quantum-chemical NMR calculations. Preliminary bioactivity screening and molecular docking analysis revealed that several natural products exhibited obvious enzyme inhibitory activities against acetylcholinesterase (AChE), such as 2,3,6,8-tetrahydroxy-1-methylxanthone (<b>4</b>) with an inhibitory rate 86% at 50 μg/mL.
ISSN:1660-3397